An analysis of two UK juvenile idiopathic arthritis registries suggests no significant difference in uveitis risk among patients treated with the TNF inhibitor etanercept relative to methotrexate.
In the first of a two-part series, Dafna Gladman, Philip Mease, and Oliver FitzGerald discuss the development of the recent ACR–NPF guidelines for the management of psoriatic arthritis, and the key differences between these and the EULAR and GRAPPA guidelines.
An analysis of two UK juvenile idiopathic arthritis registries suggests no significant difference in uveitis risk among patients treated with the TNF inhibitor etanercept relative to methotrexate.
People with gout and hyperuricemia who achieve guideline-recommended serum uric acid levels below 0.36 mmol/L have lower risks for overall and cardiovascular mortality than those who do not meet this target, researchers report.
Findings from a systematic review and meta-analysis indicate that social support may have a beneficial effect on some outcomes after knee or hip replacement surgery.
In the first of a two-part series, Dafna Gladman, Philip Mease, and Oliver FitzGerald discuss the development of the recent ACR–NPF guidelines for the management of psoriatic arthritis, and the key differences between these and the EULAR and GRAPPA guidelines.
People with rheumatoid arthritis who switch between different biologic or targeted synthetic DMARDs have a higher risk for venous thromboembolism than those who remain on the same treatment, researchers report.
medwireNews takes a look at the efficacy and safety profiles of JAK inhibitors for the treatment of rheumatoid arthritis, and addresses some common questions about their use.
Rheumatoid arthritis patients treated with the JAK1 selective inhibitor upadacitinib experience greater improvement in the signs and symptoms of disease than those given placebo or adalimumab, indicate findings from the SELECT-COMPARE trial.
The anti‐nerve growth factor monoclonal antibody fasinumab improves pain and function in patients with knee or hip osteoarthritis who have a history of inadequate response or intolerance to analgesics, study findings indicate.
